---
id: idsa-infective-endocarditis-2024
title: "AHA/IDSA 2024 Scientific Statement: Infective Endocarditis in Adults"
short_title: "AHA/IDSA IE 2024"

organization: American Heart Association
collaborators:
  - Infectious Diseases Society of America
country: US
url: https://www.heart.org/en/professional/science
doi: null
pmid: null
open_access: true

specialty: infectious-disease
guideline_type: clinical-practice
evidence_system: AHA/IDSA
conditions:
  - infective endocarditis
  - IE
  - prosthetic valve endocarditis
tags:
  - Duke criteria
  - blood cultures
  - echocardiography
  - surgery
  - antibiotic therapy

publication_date: 2024-05-01
previous_version_date: 2015-10-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-24
---

## Scope
2024 AHA/IDSA scientific statement on the diagnosis and management of infective endocarditis (IE) in adults.

## Key Recommendations

### Diagnosis

#### Modified Duke Criteria (2023 Revision)
- **Major Criteria**:
  - Blood cultures positive for typical IE organisms.
  - Evidence of endocardial involvement on imaging (echocardiography, CT, PET).
- **Minor Criteria**: Predisposing condition, fever, vascular phenomena, immunologic phenomena, positive blood cultures not meeting major criteria.

#### Echocardiography
- **TTE**: Initial test.
- **TEE**: Higher sensitivity, especially for prosthetic valves, complications (abscess, perforation), or inconclusive TTE.

#### Advanced Imaging
- Cardiac CT, 18F-FDG PET/CT: Useful for prosthetic valve IE, cardiac implantable electronic device (CIED) infections, and detecting extracardiac complications.

### Antibiotic Therapy
- **Empiric**: Vancomycin + ceftriaxone (or ampicillin-sulbactam) pending culture data.
- **Native Valve Streptococcal IE**: Penicillin G or ceftriaxone x 4 weeks (or 2 weeks with aminoglycoside in highly susceptible strains).
- **Staphylococcal IE (MSSA)**: Nafcillin or cefazolin x 6 weeks.
- **Staphylococcal IE (MRSA)**: Vancomycin or daptomycin x 6 weeks.
- **Prosthetic Valve IE**: Longer duration (â‰¥6 weeks); often requires rifampin for staphylococcal infections.

### Surgery
- **Indications**: Heart failure from valve dysfunction, uncontrolled infection (abscess, enlarging vegetation despite therapy), embolic events (especially recurrent or large vegetations >10 mm), fungal or highly resistant organisms.
- Early surgical consultation is recommended.

### Prevention
- Antibiotic prophylaxis for high-risk patients (prosthetic valves, prior IE, certain CHD) undergoing dental procedures.

### PWID-Associated IE
- Multidisciplinary approach including addiction medicine. Consider harm reduction strategies.
